Science
Israeli’s anti-virus spray to begin UK clinical trials this week – Jewish News
SaNOtize Nitric Oxide Nasal Spray, developed by a firm co-founded by Israeli Gilly Regev, is believed to kill up to 99.9% of the coronavirus that causes Covid-19….
The first UK clinical trials of a nasal spray developed by a company co-founded by an Israeli that kills 99.9% of the coronavirus that causes Covid-19, begins this week.
The SaNOtize Nitric Oxide Nasal Spray (NONS) is designed to kill the virus in the upper airways, preventing it from incubating and spreading to the lungs.
The treatment, developed by SaNOtize Research and Development Corp. based in Vancouver, Canada, co-founded by Israeli Gilly Regev, proved 99.9% effective in killing the coronavirus…
-
Noosa News17 hours agoFirst home buyers’ options to almost double under expanded Home Guarantee Scheme
-
General24 hours agoAnge Postecoglou returns to Premier League management with Nottingham Forest after Nuno Espírito Santo sacking
-
Business20 hours agoBrokers name 3 quality ASX 200 shares to buy today
-
Business18 hours agoMorgans says these ASX shares could rise 30%+